Psych management Flashcards
Depression
- Assessment of suicide risk and identifying safeguarding concerns.
- Consider any other mental or psychical comorbidity.
- Psychoeducation: sleep hygiene, diet, avoiding smoking and alcohol, exercise.
- Validated depression questionnaire (Beck Depression Inventory, PHQ9, BDI-II or Hospital Anxiety and Depression Scale).
- Arrange further assessment within 2w.
- Give advice about MIND, Depression Alliance, Depression UK, Samaritans.
Persistent subthreshold symptoms or mild-moderate depressive symptoms
1. Low intensity therapy: 8 sessions of self-help CBT, computerised CBT, structured group programme. Accessed through IAPT or referral.
2. Medication is not routinely used but may be considered for patients with a history of moderate or severe depression, subthreshold symptoms present for 2y, mild depression complicating care of a chronic physical condition.
3. Consider antidepressants if low-intensity therapy fails.
• If symptoms are subthreshold, provide information about the natural history of depression and arrange follow-up within 2w.
Persistent moderate-severe depressive symptoms
- High intensity intervention: 16 sessions over 3m of CBT, interpersonal therapy, behavioural couples therapy.
- SSRI (sertraline) until 6m after remission. Consider suicide risk and toxicity.
- Treatments can be combined.
- Arrange an initial review within 2w and every 4w for the first 3m before considering longer intervals.
- If symptoms do not respond within 4w, check adherence and side effects and either increase dose or change drug. Switching should be done by cross tapering.
Severe and complex depression
- High intensity intervention: 16 sessions over 3m of CBT, interpersonal therapy, behavioural couples therapy.
- SSRI (sertraline) for at least 2y at effective dose. Consider suicide risk and toxicity.
- Crisis resolution and home treatment team involvement.
- Crisis plan to identify triggers and strategies.
- Treatments can be combined.
- Inpatient care.
- Consider ECT for acute treatment. Absolutely contraindicated if patient has phaeochromocytoma. Relatively contraindicated if patient has had MI/stroke in past 3m, raised ICP, SOL, arterial hypertension, acute glaucoma, narcotic intolerance, cerebral aneurysm/angioma.
- Arrange an initial review within 1w and frequently thereafter until the risk is not clinically important.
- If symptoms do not respond within 4w, check adherence and side effects and either increase dose or change drug. Switching should be done by cross tapering.
Mania and bipolar affective disorder
Management
1. Refer all suspected BPAD (including hypomania) to CMHT to confirm, treat and establish a care plan. Consider urgent referral if person presents with mania, severe depression or risk to self/others.
• While awaiting assessment, consider tapering antidepressants on specialist advice if mania develops.
• Advise person to stop driving during acute illness.
2. If admission is required, persuade them to go voluntarily. Compulsory admission may be used if person requires assessment/treatment in hospital and needs to be admitted in interests of themselves or others.
3. For the mania: in secondary care, offer therapeutic trial of antipsychotic PO (haloperidol, olanzapine, quetiapine, risperidone). If one is ineffective, use a second.
4. For the mania: If a second is ineffective, add lithium or sodium valproate. Avoid sodium valproate in pre-menopausal women. If already taking lithium, check dose and compliance and consider adding an antipsychotic.
5. For the depression: offer fluoxetine with olanzapine/quetiapine first then lamotrigine alone as second-line. Quetiapine alone or olanzapine alone may be considered. Monitor closely for mania and withdraw cautiously if symptom-free for a sustained period.
6. Secondary care team should discuss the long-term plan. Patient can continue treatment or start long-term treatment with lithium +/- valproate. Valproate or olanzapine alone may be considered.
7. High-intensity CBT for depression or psychodynamic psychotherapy for BPAD may be offered.
8. A care plan should include social and emotional recovery goals, assessment of mental state, a crisis plan, medication plan, an advanced statement for future treatment, a statement of financial affairs, care of pets or at-risk relatives and key contacts in case of emergency.
9. Monitor patient for at least 12m or until condition stabilised. Re-refer to secondary care if function declines, adherence is poor, substance misuse is suspected or a woman is planning to conceive.
• Benzodiazepines may be useful in the acute treatment of manic episodes.
Psychosis and schizophrenia
Management
- For first episode of psychosis, offer assessment in primary care including risk to self (self-harm, suicidal ideation and attempts, substance abuse, accidental or non-accidental injury), potential for neglect of dependent persons, risk to public, risk from others.
- Arrange same day assessment by Early Intervention in Psychosis team. If unavailable, refer to a crisis resolution and home treatment team. Do not start anti-psychotics.
- Consider use of sections 2 or 4 of MHA for admission.
- Offer family therapy (10 sessions over 1y), individual CBT (16 sessions), arts therapies (for negative symptoms). Treat any co-existing anxiety, depression, substance misuse or emergency personality disorder.
- Offer a trial of oral antipsychotic in conjunction. Titrate the dose up to optimum dosage over 4-6w.
- A care plan should include social and emotional recovery goals, assessment of mental state, a crisis plan, medication plan, an advanced statement for future treatment, a statement of financial affairs, care of pets or at-risk relatives and key contacts in case of emergency.
- Monitor patient for at least 12m or until condition stabilised in secondary care. Then responsibility may be transferred to primary care. Assess symptom control, deterioration at work/school/socially, anxiety/depression, adherence and side effects, alcohol and substance misuse. Measure weight (weekly for 6w, then 12w, then annually), waist circumference (annually), HR and BP (12w, 1y then annually) and fasting glucose, HbA1c, lipids, U&E, FBC, LFT, prolactin (12w, 1y then annually). Perform an ECG if person is taking haloperidol, pimozide or sertindole.
- People that do not have a clear diagnosis of a psychotic disorder should be monitored in secondary care for up to 3y.
- Give advice about MIND, British Association for Supported Employment.
- Re-refer to secondary care if function declines, adherence is poor, side effects are intolerance, substance abuse is suspected, a woman is planning to conceive or there is potential risk to the person or others.
- When stopping, withdraw gradually and monitor regularly for relapse signs. Continue monitoring for 2y.
• Inform patient that they must not drive during an acute episode and must inform the DVLA.
Postnatal depression
Management
1. Consider referral for high-intensity psychological intervention. Assess within 2w of referral.
2. Consider medication: TCA (imipramine, nortriptyline), SSRI (paroxetine, sertraline) or SNRI. Monitor baby for sedation, poor feeding and behavioural effects. Do not prescribe valproate and avoid lithium where possible.
3. Consider hospital admission for severe depression with suicidal or infanticidal ideation. A Mother and Baby Unit it ideal for this.
• For subthreshold symptoms, consider referral for facilitated self-help. Consider medical treatment if there is a previous history of severe depression.
Puerperal psychosis
Management
- Encourage women to breastfeed unless they are taking carbamazepine, clozapine or lithium. If she chooses to breastfeed on these medications, advise the woman to give her baby a formula feed at night after taking medication and breastfeed in the daytime.
- Consider the use of TCAs, SSRIs or SNRIs.
- Assess and discuss the nature of the mother-baby relationship.
- Arrange admission to the Mother and Baby Unit.
- Benzodiazepines may be used in the short term for sedation.
- ECT may be used in severe psychosis.
- Arrange for midwives to visit daily until 14-28w postpartum.
- When stopping, gradually reduce antipsychotic.
Autism
Management
- Use play-based strategies with parents and teachers to increase attention and communication. Adjust the environment as needed.
- Treat physical or co-existing mental health problems.
- Use psychosocial interventions as first line: applied behavioural analysis (a reward system for children <3y), Early Start Denver model, More Than Words programme (for children <6 with social and communication difficulties).
- Develop sleep plan for sleep hygiene. Refer to paediatric sleep specialist if sleep is disturbed. Offer respite breaks for carers.
- Use pharmacological interventions second-line: consider antipsychotics if severe behavioural challenges starting at low dose for 6w. Stop if no response.
- Refer parents to the National Autistic society and National Autistic Society schools.
Attention deficit-hyperactivity disorder
Management
• Behavioural management with clear expectations and rewards.
• Use drug holidays to limit growth retardation.
Children <5y
- Refer child to paediatric psychiatrist.
- Offer ADHD-focused group parent-training programmes without awaiting a formal diagnosis. If ineffective, obtain advice from a specialist ADHD service.
- Do not start medication without a second specialist opinion.
Children >5y
- Offer children >5y ADHD-focused group parent-training programmes. Consider individual programmes if symptoms of conduct disorder or oppositional defiance disorder.
- Offer medication if ADHD symptoms are causing persistent significant impairment in at least one domain after environmental changes have been implemented and reviewed.
- Carry out baseline assessment of past medical history, drug history, height, weight, HR, BP and cardiovascular exam.
- Use methylphenidate first line for 6w. Titrate slowly up to adequate dose.
- Use lisdexamfetamine second line for 6w if this is ineffective.
- Use dexamfetamine is the long-acting effects of lisdexamfetamine are not tolerated.
- Use non-stimulant noradrenaline reuptake inhibitors atomoxetine or guanfacine.
- Monitor height, HR and BP every 6m, monitor weight every 3m if <10 and every 6m thereafter, plot growth. Do not perform ECG routinely. Stop medication if it precipitates an acute psychotic or manic episode.
- Consider a course of CBT for young people who have benefited from medication but whose symptoms still cause significant impairment.
Adults
- Structured supportive psychological intervention for ADHD, possibly with CBT.
- Methylfenidate or lisdexamfetamine.
- Atomoxetine.
Alcohol misuse
Management
- Motivational interviewing and structured brief to empower the person to change.
- If homeless, offer residential rehabilitation for a maximum of 3m. Uncomplicated dependency may be managed in the community but a history of withdrawal fits, comorbid medical or psychiatric illness or lack of support necessitates inpatient detoxification.
- Urgently admit patients with signs of delirium tremens or Wernicke’s encephalopathy. Offer chlordiazepoxide for detoxification using a fixed-dosage reducing regimen over 5-7d. Consider the use of lorazepam instead of chlordiazepoxide for patients in acute withdrawal. Use lorazepam in patients with hepatic impairment.
- Offer prophylactic PO pabrinex to patients with mild dependence. Offer IV or IM thiamine for 5d to patients with signs of delirium tremens or Wernicke’s encephalopathy.
- Refer patients with co-morbid mental health conditions to mental health services.
- Consider offering CBT, group therapy or social network therapy. Children should receive family therapy for 3m.
- Offer acomprosate 2000mg OD and disulfiram 200mg OD to promote abstinence following detoxification for 6m. Consider the use of naltrexone starting at 25mg OD aiming for a maintenance dose of 50mg OD.
- Offer supported independent living for those with Wernicke-Korsakoff syndrome.
- Advise patients that they should notify the DVLA and surrender their license for a period.
Opiate misuse
Management
- Provide information about self-help groups.
- Offer opioid detoxification and withdrawal treatment unless the patient has a concurrent medical problem requiring urgent treatment, is in police custody or is pregnant.
- Appoint a key worker to support the person. Use PO methadone or sublingual buprenorphine for detoxification. For mild dependence or patients keen to detoxify over a shorter period, consider lofexidine. Inpatient admission for patients with significant comorbidities is for 4w, community detoxification takes 12w.
- Promote abstinence, prevent relapse and reduce the risk of HIV and HCV transmission. Consider naltrexone to prevent relapse.
- Refer to Drugs and Alcohol Service for 6m and offer CBT to prevent relapse.
- Consider contingency management: offer incentives for each negative drug test and reduce frequency of screening over time.
Anorexia nervosa
Management
1. Psychoeducate the person on nutrition and health. Offer dietary counselling and encourage multivitamin and mineral supplement.
2. Treat comorbid psychiatric illness.
3. Set realistic weekly weight gain targets (0.5-1kg weekly) and set an eating plan.
4. Offer psychotherapy such as motivational interviewing, FT-AN (20 sessions over 1y), IPT, MANTRA (20 sessions for adults) or CBT-AN (4o sessions over 4w).
5. Consider medical treatment if the person has physical complications, is rapidly losing weight or has BMI <13.5. Consider inpatient treatment if BMI <13, there are serious physical complications or a high suicide risk. The MHA may be necessary for compulsory feeding.
6. Do not offer medication as sole treatment for AN.
7. Monitor person and involve family in helping them achieve a healthy body weight.
8. Alert the patient’s record to highlight the potential risks of adverse drug effects.
Mild anorexia nervosa
If BMI >17 with no additional comorbidity, monitor and support for 8w, give advice about BEAT and refer routinely to community Eating Disorder Service if conservative measures are ineffective.
Moderate anorexia nervosa
If BMI 15-17 but without evidence of system failure, urgently refer to EDS.
Severe anorexia nervosa
If BMI <15 with rapid weight loss, evidence of system failure (purpuric rash, cold peripheries, hypotension <80/50, bradycardia <40bpm, electrolyte imbalance or proximal myopathy) or high suicide risk, consider inpatient admission. Avoid rapid increases in daily caloric intake and closely monitor inpatients for refeeding syndrome.
Bulimia nervosa
Management
- Psychoeducate the person on nutrition and health. Offer dietary counselling and encourage multivitamin and mineral supplement.
- Treat comorbid psychiatric illness.
- Encourage those who are vomiting to have regular dental and medical reviews, avoid brushing teeth immediately after vomiting, rinse with non-acidic mouthwash after vomiting and avoid highly acidic food and drinks.
- Advise them that laxatives and diuretics do not reduce calorie absorption and do not help with weight loss — laxative or diuretic use should be gradually reduced and stopped.
- Admit those with severe compromise to a medical inpatient or day patient service for stabilisation and refeeding if these cannot be done in an outpatient setting.
- Alert the patient’s record to highlight the potential risks of adverse drug effects.
Mild bulimia nervosa
• Recommend BN-focused self-help and BEAT, monitor and support for 3m. Refer routinely to EDS if ineffective. Consider individual CBT-ED for adults. Offer FT-BN for children and, if ineffective, offer CBT-ED.
Moderate bulimia nervosa
• Monitor and support for 8w, recommend BN-focused self-help, consider use of SSRI (fluoxetine) for impulse control. Refer routinely to EDS if ineffective.
Severe bulimia nervosa
• Urgent referral to EDS.
Binge eating disorder
Management
- Offer BED-focused self-help.
- If unacceptable or ineffective after 4w, consider group CBT-ED.
- If unacceptable or ineffective, consider individual CBT-ED.
Delirium
Management
- Identify underlying cause and treat/stop it. Have a low threshold for diagnosis in patients >65y, cognitive impairment, current hip fracture or with severe illness.
- Effectively communicate and orientate the person with family’s help eg lighting, clocks, hearing aids and glasses, minimise change, allow supervised wandering, facilitate visitation.
- If patients are a risk to themselves or others, first use verbal and non-verbal de-escalation techniques. Distress may be less evident in hypoactive delirium.
- If ineffective, use the lowest clinically effective dose of haloperidol and titrate cautiously. Discontinue haloperidol after 1w. Do not use haloperidol in PD or DLB.
- Consider the use of a small nocturnal dose of benzodiazepine to correct the sleep-wake cycle.
- If delirium does not resolve, re-evaluate for underlying causes and assess for dementia.
Generalised anxiety disorder
Management
- Follow a stepped care model. Identify and communicate the diagnosis. Consider GAD in people presenting with anxiety and people who attend primary care frequently with a chronic health problem.
- Have a high suspicion of GAD in patients with somatic symptoms or patients that are repeatedly worrying about a wide range of issues.
- Assess severity and the presence of comorbid depression, substance misuse, physical health conditions and a history of mental health conditions. Monitor the person and provide education about triggers and coping techniques.
- If diagnosed, offer low-intensity therapies such as individual non-facilitated self-help and psychoeducational groups based on CBT.
Marked functional impairment
• If unimproved or with marked functional impairment, offer a choice of high-intensity individual therapy such as CBT or applied relaxation (12-15 weekly sessions) or drug treatment with an SSRI (sertraline). If ineffective, offer an alternative SSRI or SNRI and advise the patient of the initial worsening of anxiety. Monitor suicide risk for the first month. If SSRI/SNRI is not tolerated, offer pregabalin. Monitor every 2-4w for the first 3m then every 3m thereafter. If there is no response to psychology therapy, switch to medication and vice versa. If there is a partial response with medication, add a psychological intervention.
• Do not offer benzodiazepines except as a short-term measure (2-4w) during crises until long-term medications take effect.
Complex and treatment-refractory GAD
• For complex, treatment-refractory GAD with marked function impairment or high risk of self-harm, refer for specialist assessment. Combination psychological and drug treatments should be commenced by the specialist.
Anxiety in children
- Psychoeducation regarding lifestyle changes and managing stressors.
- Psychological therapy: CBT, counselling with family involvement.
- Consider fluoxetine or sertraline (for OCD) alongside psychological therapy.
Social anxiety disorder
Management
- Individual CBT based on Clark and Wells model or Heimberg model (14 sessions). Do not offer group CBT. If declined, offer CBT-based self-help.
- Offer SSRI (sertraline or escitalopram).
- If partially responsive, offer individual CBT in addition to SSRI. If ineffective after 12w, offer alternative SSRI or SNRI (venlafaxine).
- If ineffective, offer MAOi (phenylzine).
- For patients who decline all the above, consider short-term psychodynamic therapy of 30 sessions over 8m.
Children
1. Individual or group CBT (12 sessions). Do not offer medication without specialist advice.